[HTML][HTML] The role of the p53 tumor suppressor in metabolism and diabetes

CP Kung, ME Murphy - The Journal of endocrinology, 2016 - ncbi.nlm.nih.gov
In the context of tumor suppression, p53 is an undisputedly critical protein. Functioning
primarily as a transcription factor, p53 helps fend off the initiation and progression of tumors …

Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification

B Meeusen, V Janssens - The international journal of biochemistry & cell …, 2018 - Elsevier
Aberrant protein phosphorylation is one of the hallmarks of cancer cells, and in many cases
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …

The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes

BF Belgardt, K Ahmed, M Spranger, M Latreille… - Nature medicine, 2015 - nature.com
Pancreatic beta cell death is a hallmark of type 1 (T1D) and type 2 (T2D) diabetes, but the
molecular mechanisms underlying this aspect of diabetic pathology are poorly understood …

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

M Zeineldin, S Federico, X Chen, Y Fan, B Xu… - Nature …, 2020 - nature.com
Aggressive cancers often have activating mutations in growth-controlling oncogenes and
inactivating mutations in tumor-suppressor genes. In neuroblastoma, amplification of the …

Dual-specificity MAP kinase phosphatases as targets of cancer treatment

C Nunes-Xavier, C Roma-Mateo, P Rios… - Anti-Cancer Agents …, 2011 - ingentaconnect.com
The protein tyrosine phosphatase family (PTP) contains a group of dual-specificity
phosphatases (DUSPs) that regulate the activivity of MAP kinases (MAPKs), which are key …

Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus

N Hashimoto, T Tanaka - Journal of human genetics, 2017 - nature.com
MicroRNAs (miRNAs) are noncoding RNAs of~ 22 nucleotides that regulate gene
expression post-transcriptionally by binding to the 3′ untranslated region of messenger …

Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways

Z Cui, D Li, J Zhao, K Chen - Free Radical Biology and Medicine, 2022 - Elsevier
Non-small-cell lung cancer (NSCLC) is one of the most commonly diagnosed cancers
worldwide with limited effective therapies. Cisplatin (DDP), as the first-line treatment, is …

Maintaining genome integrity: Protein kinases and phosphatases orchestrate the balancing act of DNA double-strand breaks repair in cancer

S Qin, I Kitty, Y Hao, F Zhao, W Kim - International Journal of Molecular …, 2023 - mdpi.com
DNA double-strand breaks (DSBs) are the most lethal DNA damages which lead to severe
genome instability. Phosphorylation is one of the most important protein post-translation …

The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth

H Kim, HJ Lee, Y Oh, SG Choi, SH Hong… - Nature …, 2014 - nature.com
Abstract Adenylate kinase 2 (AK2), which balances adenine nucleotide pool, is a multi-
functional protein. Here we show that AK2 negatively regulates tumour cell growth. AK2 …

Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

RE Norris, PC Adamson, VT Nguyen… - Pediatric blood & …, 2014 - Wiley Online Library
Background Poly (ADP‐ribose) polymerase (PARP) signals DNA damage and facilitates
DNA repair. PARP inhibitors are being evaluated in cancers with defective DNA repair …